| Q37190605 | A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria |
| Q28082023 | Advances in genetics and genomics: use and limitations in achieving malaria elimination goals |
| Q37284080 | An informatics model for guiding assembly of telemicrobiology workstations for malaria collaborative diagnostics using commodity products and open-source software |
| Q24614989 | Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria |
| Q34084173 | Artemisone effective against murine cerebral malaria |
| Q35006418 | Discovery, mechanisms of action and combination therapy of artemisinin |
| Q28655984 | Emerging Plasmodium vivax resistance to chloroquine in South America: an overview |
| Q38090355 | Folate metabolism in human malaria parasites—75 years on |
| Q37802635 | How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance |
| Q34485984 | Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN) |
| Q38225084 | Improving the role and contribution of pharmacokinetic analyses in antimalarial drug clinical trials. |
| Q39224800 | In vitro evaluations of antimalarial drugs and their relevance to clinical outcomes |
| Q41833044 | In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene: the absence of association in clinical isolates from the Republic of Congo |
| Q36921820 | In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger transporter (Pfnhe-1) gene in 393 isolates from Dakar, Senegal |
| Q36955257 | Malaria research and its influence on anti-malarial drug policy in Malawi: a case study |
| Q27974553 | Modulation of PF10_0355 (MSPDBL2) alters Plasmodium falciparum response to antimalarial drugs |
| Q57551335 | Molecular Markers of Plasmodium Resistance to Antimalarials |
| Q33512515 | Molecular genomic approaches to infectious diseases in resource-limited settings |
| Q37225083 | Monitoring antimalarial drug efficacy: current challenges |
| Q37390583 | Monitoring antimalarial drug resistance: Applying lessons learned from the past in a fast-moving present. |
| Q34601191 | Multinormal in vitro distribution model suitable for the distribution of Plasmodium falciparum chemosusceptibility to doxycycline |
| Q35068138 | Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine |
| Q37316906 | PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum malaria |
| Q37190763 | Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine |
| Q33645352 | Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance |
| Q36711959 | Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study |
| Q36316217 | Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal |
| Q37283037 | Recent highlights in antimalarial drug resistance and chemotherapy research |
| Q33723453 | Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations |
| Q34597550 | Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin |
| Q37008611 | Scaling up impact of malaria control programmes: a tale of events in Sub-Saharan Africa and People's Republic of China |
| Q41931788 | Sentinel network for monitoring in vitro susceptibility of Plasmodium falciparum to antimalarial drugs in Colombia: a proof of concept |
| Q28534753 | Surveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countries |
| Q37130417 | The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa |
| Q34541163 | Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs |